 Home > Active Ingredient News > Antitumor Therapy > EHA 2021 first look: Where is the "gap" in the treatment of relapsed and refractory Hodgkin's lymphoma in China?

EHA 2021 first look: Where is the "gap" in the treatment of relapsed and refractory Hodgkin's lymphoma in China?

 Last Update: 2021-06-11
 Source: Internet
 Author: User

Tags

new treatment tourette's

2 novacare way

bear skin cloak

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Statement This information is intended to help medical and health professionals better understand the latest developments in the field of related diseases.

The content of the information published by this site does not mean that it agrees with its description and opinions, but only provides more information.

If copyright issues are involved, please contact us, and we will deal with it as soon as possible.

Only for medical and health professionals to understand the information.

Such information cannot replace professional medical guidance in any way, nor should it be regarded as diagnosis and treatment advice.

If such information is used for purposes other than understanding the information, this site and the author shall not bear related responsibilities.

RECOMMEND recommended reading 1.
Verbutuximab adds another indication! Domestic skin T-cell lymphoma usher in new hope 2.
2021 CSCO lymphoma diagnosis and treatment guidelines are updated, and verbutuximab is included

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gefitinib

CAS No.: 184475-35-2

Pharmacy Grade

$1/MT FOB

High quality Sunitinib CAS NO 557795-19-4 Orange solid powder 99% API for antitumor

CAS No.: 557795-19-4

Pharmacy Grade

$4.1-4.2/G FOB

Epirubicin

CAS No.: 56420-45-2

$1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.